A phase 2, open-label, investigator-initiated study to evaluate the safety and efficacy of apremilast in subjects with recalcitrant allergic contact or atopic dermatitis (Q83585186)
Jump to navigation
Jump to search
scientific article published on 01 March 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase 2, open-label, investigator-initiated study to evaluate the safety and efficacy of apremilast in subjects with recalcitrant allergic contact or atopic dermatitis |
scientific article published on 01 March 2012 |
Statements
A phase 2, open-label, investigator-initiated study to evaluate the safety and efficacy of apremilast in subjects with recalcitrant allergic contact or atopic dermatitis (English)
Eva M Volf
Shiu-Chung Au
Nicole Dumont
Pamela Scheinman
Alice B Gottlieb